Skip to main content

Research Repository

Advanced Search

All Outputs (225)

Macrolides, reflux and respiratory disease (2018)
Book Chapter
Crooks, M. G., & Nash, T. (2018). Macrolides, reflux and respiratory disease. In A. H. Morice, & P. W. Dettmar (Eds.), Reflux Aspiration and Lung Disease (303-331). Springer. https://doi.org/10.1007/978-3-319-90525-9_25

Macrolides are a family of compounds that belong to the polyketides class. They are characterised by a large macrocyclic lactone ring that is produced by chain extension of propionates to which one or more sugars (usually cladinose and desosamine) at... Read More about Macrolides, reflux and respiratory disease.

XII AIST 2018 Conference: "the thousand faces of cough: Clinical and therapeutic updates" (2018)
Journal Article
Zanasi, A., Morselli-Labate, A. M., Mazzolini, M., Mastroroberto, M., Dal Negro, R. W., Poliacek, I., Morice, A. H., Maio, S., Viegi, G., Koufman, J., Torresan, F., Ioannou, A., Mandolesi, D., Liverani, E., Montale, A., Bazzoli, F., Baldi, F., Zompatori, M., Fontana, G. A., Kantar, A., …Tursi, F. (2018). XII AIST 2018 Conference: "the thousand faces of cough: Clinical and therapeutic updates". Multidisciplinary Respiratory Medicine, 13(1), Article 17. https://doi.org/10.1186/s40248-018-0130-y

© 2018 The Author(s). This paper summarizes the presentations submitted for publication of the 12th AIST National Congress (Associazione Italiana Studio Tosse/Italian Association for Cough Study) entitled "The thousand facets of cough. A clinical and... Read More about XII AIST 2018 Conference: "the thousand faces of cough: Clinical and therapeutic updates".

The role of high resolution oesophageal manometry in occult respiratory symptoms (2018)
Journal Article
Burke, J. M., Jackson, W., & Morice, A. H. (2018). The role of high resolution oesophageal manometry in occult respiratory symptoms. Respiratory medicine, 138, 47-49. https://doi.org/10.1016/j.rmed.2018.03.027

Purpose: Cough Hypersensitivity Syndrome is the urge to cough following minimal stimulation, but its mechanism and method of provocation remain unexplained. 121 patients (44 males, 77 females; age range 18–81 years) were evaluated. Procedures: High r... Read More about The role of high resolution oesophageal manometry in occult respiratory symptoms.

The effect of pH on citric acid cough challenge: A randomised control trial in chronic cough and healthy volunteers (2018)
Journal Article
Rai, Z. L., Fowles, H. E., Wright, C., Howard, J., & Morice, A. H. (2018). The effect of pH on citric acid cough challenge: A randomised control trial in chronic cough and healthy volunteers. Respiratory Physiology and Neurobiology, 257, 51-54. https://doi.org/10.1016/j.resp.2018.02.013

© 2018 Elsevier B.V. Introduction: Citric acid has been used for over six decades to induce cough; however the mechanism of its pro-tussive effect is still not fully understood. We assessed the response to inhalation of citric acid at varying levels... Read More about The effect of pH on citric acid cough challenge: A randomised control trial in chronic cough and healthy volunteers.

Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy (2018)
Journal Article
Sadeghi, M. H., Wright, C. E., Hart, S., Crooks, M., & Morice, A. (2018). Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy. Annals of Allergy, Asthma and Immunology, 120(3), 285-291. https://doi.org/10.1016/j.anai.2017.12.004

© 2017 Background: Whether the fraction of exhaled nitric oxide (FeNO) measurement can predict the response to anti-inflammatory treatment in chronic cough is unknown. Objective: To explore whether the effectiveness of treatment with 10 mg of montelu... Read More about Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy.

Is cough important in acute exacerbations of COPD? (2018)
Journal Article
Crooks, M. G., Brown, T., & Morice, A. H. (2018). Is cough important in acute exacerbations of COPD?. Respiratory Physiology and Neurobiology, 257, 30-35. https://doi.org/10.1016/j.resp.2018.02.005

Chronic obstructive pulmonary disease is predicted to become the 4th leading cause of death worldwide by 2030. The natural history of the disease includes progressive symptoms punctuated by acute exacerbations during which symptoms rapidly deteriorat... Read More about Is cough important in acute exacerbations of COPD?.

A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels (2017)
Journal Article
Haughney, J., Morice, A., Blyth, K. G., Lee, A. J., Coutts, A., McKnight, E., & Pavord, I. (2018). A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels. Respiratory medicine, 134, 117-123. https://doi.org/10.1016/j.rmed.2017.12.001

© 2017 Elsevier Ltd Background Identifying asthma patients suitable for biologic therapy includes the assessment of blood biomarkers (IgE and eosinophils (EOS)). How they relate to each other is unclear. Methods This retrospective, database study use... Read More about A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.

Asthma phenotypes: Do cough and wheeze predict exacerbations in persistent asthma? (2017)
Journal Article
Morjaria, J. B., Rigby, A. S., & Morice, A. H. (2017). Asthma phenotypes: Do cough and wheeze predict exacerbations in persistent asthma?. European respiratory journal, 50(6), Article 1701366. https://doi.org/10.1183/13993003.01366-2017

Copyright © ERS 2017. Little is known of the long-term symptom profile in uncontrolled asthma and whether symptoms can predict distinct phenotypes. The primary objective of these analyses was to assess diurnal profile of cough and wheeze in an uncont... Read More about Asthma phenotypes: Do cough and wheeze predict exacerbations in persistent asthma?.

Does FeNO Predict Clinical Characteristics in Chronic Cough? (2017)
Journal Article
Sadeghi, M. H., Wright, C. E., Hart, S., Crooks, M., & Morice, A. H. (2018). Does FeNO Predict Clinical Characteristics in Chronic Cough?. Lung, 196(1), 59-64. https://doi.org/10.1007/s00408-017-0074-6

© 2017, The Author(s). Purpose: To evaluate whether exhaled nitric oxide measurement can facilitate in the assessment of chronic cough patients based on their airway inflammatory phenotype. Methods: We have studied consecutive patients attending a sp... Read More about Does FeNO Predict Clinical Characteristics in Chronic Cough?.

Pharmacology of cough in palliative care (2017)
Journal Article
Morice, A. H., & Shanks, G. (2017). Pharmacology of cough in palliative care. Current opinion in supportive and palliative care, 11(3), 147-151. https://doi.org/10.1097/SPC.0000000000000279

© 2017 Wolters Kluwer Health, Inc. All rights reserved. Purpose of review Cough is a common and distressing symptom. It has a marked decrement on quality-of-life particularly in the arena of palliative care where coexisting symptoms such as pain may... Read More about Pharmacology of cough in palliative care.

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial (2017)
Journal Article
Birring, S. S., Wijsenbeek, M. S., Agrawal, S., van den Berg, J. W., Stone, H., Maher, T. M., Tutuncu, A., & Morice, A. (2017). A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. The lancet. Respiratory medicine, 5(10), 806-815. https://doi.org/10.1016/S2213-2600%2817%2930310-7

Background Cough can be a debilitating symptom of idiopathic pulmonary fibrosis (IPF) and is difficult to treat. PA101 is a novel formulation of sodium cromoglicate delivered via a high-efficiency eFlow nebuliser that achieves significantly higher dr... Read More about A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.